Effectiveness of quetiapine in patients with bipolar I and II depression: A multi-center, prospective, open-label, observational study

被引：0
|
作者：
Jeong, J. -H. [1 ]
Bahk, W. -M. [2 ]
Woo, Y. S. [3 ]
Seo, H. -J. [3 ]
Hong, S. -C. [3 ]
Jon, D. -I. [4 ]
Cho, H. -S. [5 ]
Yoo, S. Y. [6 ]
Min, K. J. [7 ]
Yoon, B. -H. [8 ]
机构：
[1] Catholic Univ Kor, St Vincents Hosp, Suwon, South Korea
[2] Catholic Univ Kor, Seoul, South Korea
[3] Catholic Univ Kor, Suwon, South Korea
[4] Hallym Univ, Anyang, South Korea
[5] Yonsei Univ, Seoul 120749, South Korea
[6] Astrazenca, Seoul, South Korea
[7] Cung Ang Univ, Seoul, South Korea
[8] Naju Natl Hosp, Naju, South Korea
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2010年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：126 / 126
页数：1
相关论文
共 50 条
  • [1] Effectiveness of quetiapine in bipolar depression patients: a multi-centre, prospective, open-label, observational study
    Jeong, J.
    Bahk, W. M.
    Woo, Y. S.
    Min, K. J.
    Jon, D. I.
    Yoon, B. H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S409 - S409
  • [2] Efficacy of quetiapine in patients with bipolar I and II depression: a multicenter, prospective, open-label, observational study
    Jeong, Jong-Hyun
    Bahk, Won-Myong
    Woo, Young Sup
    Seo, Ho-Jun
    Hong, Seung-Chul
    Jon, Duk-In
    Min, Kyung Joon
    Yoon, Bo-Hyun
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 197 - 204
  • [3] A prospective open-label study of ziprasidone augmentation for bipolar I depression
    Printz, D
    Stricks, L
    Flater, S
    Malaspina, D
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S327 - S327
  • [4] Efficacy and safety of paliperidone ER in patients with first episode psychosis: An open-label, prospective, multi-center study
    Chung, Y. -C.
    Park, J. -I.
    Cho, D. -H.
    Hahn, S. -W.
    Han, C.
    Jung, M. H.
    Kim, J. -H.
    Kim, S. -W.
    Lee, K. Y.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 67 - 67
  • [5] Upadacitinib for Refractory Behcet's Syndrome: A Multi-center, Prospective, Open-label, Pilot Study
    Xia, Weiyi
    Li, Jiachen
    Liu, Tian
    Li, Yuhui
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 5121 - 5122
  • [6] Open-Label, Multi-Center Phase I Dose Escalation Study with Lenalidomide In Patients with Acute Myeloid Leukemia
    Huetter, Marie-Luise
    Fiedler, Walter
    Kuendgen, Andrea
    Krauter, Juergen
    von Lilienfeld-Toal, Marie
    Kayser, Sabine
    Rafler, Heidi
    Doehner, Hartmut
    Schlenk, Richard F.
    BLOOD, 2010, 116 (21) : 1350 - 1351
  • [7] ESCITALOPRAM VS BUPROPION AS ADJUNCTIVE TREATMENT FOR ACUTE BIPOLAR I DEPRESSION: A MULTI-CENTER OPEN LABEL TRIAL
    Raju, Chithra Pream
    Qian, Hong
    Arumugham, Shyam Sundar
    Kesavan, Muralidharan
    Wong, Hubert
    Yc, Janardhan Reddy
    Yatham, Lakshmi N.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 : i120 - i121
  • [8] BLONANSERIN AUGMENTATION IN PATIENTS WITH SCHIZOPHRENIA - WHO IS BENEFITED FROM BLONANSERIN AUGMENTATION? AN OPEN-LABEL, PROSPECTIVE, MULTI-CENTER STUDY
    Bahk, Won-Myong
    Kwon, Young Joon
    Yoon, Bo-Hyun
    Lee, Sang-Yeol
    Lee, Kwanghun
    Jon, Duk-In
    Kim, Moon Doo
    Lim, Eunsung
    SCHIZOPHRENIA BULLETIN, 2018, 44 : S411 - S411
  • [9] Lurasidone in bipolar I depression: a 24 week, open-label extension study
    Ketter, T.
    Pikalov, A.
    Sarma, K.
    Silva, R.
    Kroger, H.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S443 - S444
  • [10] Lurasidone in Bipolar I Depression: A 24 Week, Open-label Extension Study
    Ketter, Terence
    Sarma, Kaushik
    Silva, Robert
    Xu, Jane
    Cucchiaro, Josephine
    Loebel, Antony
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S534 - S535
12345